Category: Synthetic drugs
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
National Drug Early Warning System
This new system will monitor emerging drug trends that will help health experts identify increasing use of designer synthetic compounds.
New to drug testing: Synthetic stimulants
Synthetic compounds change frequently and our scientific experts must monitor, and adjust our testing panels to an ever-changing list of substances.
New to drug testing: Synthetic marijuana
In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
Quest Diagnostics now tests for synthetic stimulants (bath salts)
Quest Diagnostics offers a comprehensive suite of drug testing products and services which now includes testing for synthetic stimulants (bath salts).
Synthetic cannabinoid user profile
The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of the CESAR report.
Synthetic cannabinoids linked to acute kidney injury
Acute kidney injury following exposure to synthetic cannabinoids, in sixteen cases, has been identified in six states.
DEA operation log jam
The DEA's Operation Log Jam was the first-ever nationwide law enforcement action against synthetic drugs.
Law battles synthetic drugs
President Obama signed the Synthetic Drug Abuse Prevention Act of 2012 into law, banning synthetic marijuana, synthetic stimulants and hallucinogens.
